Physician profile
Stacie L Setchell
NPI 1528220670
$15,587.84
in general payments reported to CMS, 2019-2025
16 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,548 · 2020: $5,500 · 2021: $767 · 2022: $92.01 · 2023: $152 · 2024: $304 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $14,648.08 | 2019-2024 | Photrexa |
| Coopervision INC. | $182.56 | 2021 | |
| Alcon Vision LLC | $155.49 | 2021-2024 | Total30, Eysuvis |
| Harrow Eye, LLC | $96.31 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $76.30 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $70.21 | 2023-2025 | Vyzulta |
| Amgen INC. | $59.86 | 2024 | Tepezza |
| Sun Pharmaceutical Industries INC. | $59.62 | 2019-2025 | |
| Horizon Therapeutics Plc | $58.81 | 2023 | Tepezza |
| Oyster Point Pharma, INC. | $53.42 | 2023-2024 | Tyrvaya, Ryzumvi |
| The Cameron-Ehlen Group, INC. | $29.69 | 2021 | |
| Kala Pharmaceuticals, INC. | $28.56 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $21.24 | 2019 | |
| Allergan, INC. | $19.24 | 2021 | |
| Quidel Corporation | $14.43 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $14.02 | 2024 | Cirrus Hd-Oct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacie Setchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.